JOHNSON & JOHNSON Long-Term Concentrated

Location: New Brunswick, NJ

CIK: 0000200406 · Show all filings

Period: Q3 2026 (← Previous)

Filing Date: Oct 26, 2026

Total Value: $762M (100.0% shares, 0.0% debt)

Holdings (15)

Increased Positions (1)

Unchanged Positions (14)

PTGX PROTAGONIST THERAPEUTICS INC 45.3%
Value $345M Shares 2,449,183 Share Price $140.89 Est. Cost/Share $42.63 Unrealized @ Report Date +230.5%
NBTX NANOBIOTIX 23.0%
Value $175M Shares 5,623,816 Share Price $31.16 Est. Cost/Share $6.67 Unrealized @ Report Date +367.1%
MGTX MEIRAGTX HLDGS PLC 9.6%
Value $73.05M Shares 6,641,064 Share Price $11.00 Est. Cost/Share $9.84 Unrealized @ Report Date +11.7%
RAPP RAPPORT THERAPEUTICS INC 7.9%
Value $59.96M Shares 1,784,517 Share Price $33.60 Est. Cost/Share $23.15 Unrealized @ Report Date +45.1%
CVRX CVRX INC 0.9%
Value $7.044M Shares 4,024,861 Share Price $1.75 Est. Cost/Share $19.85 Unrealized @ Report Date -91.2%
LEGN LEGEND BIOTECH CORP 2.1%
Value $16.2M Shares 814,586 Share Price $19.89 Est. Cost/Share $41.61 Unrealized @ Report Date -52.2%
XNCR XENCOR INC 2.5%
Value $18.66M Shares 748,062 Share Price $24.95 Est. Cost/Share $37.91 Unrealized @ Report Date -34.2%
CTNM CONTINEUM THERAPEUTICS INC 3.5%
Value $26.56M Shares 1,979,173 Share Price $13.42 Est. Cost/Share $16.10 Unrealized @ Report Date -16.7%
NMRA NEUMORA THERAPEUTICS INC. 0.1%
Value $1.103M Shares 1,849,445 Share Price $0.60 Est. Cost/Share $12.57 Unrealized @ Report Date -95.3%
PRCT PROCEPT BIOROBOTICS CORP 0.9%
Value $6.522M Shares 357,939 Share Price $18.22 Est. Cost/Share $38.38 Unrealized @ Report Date -52.5%
FATE FATE THERAPEUTICS INC 1.1%
Value $8.008M Shares 3,379,064 Share Price $2.37 Est. Cost/Share $78.44 Unrealized @ Report Date -97.0%
VOR VOR BIOPHARMA INC 0.1%
Value $1.025M Shares 53,732 Share Price $19.08 Est. Cost/Share $18.62 Unrealized @ Report Date +2.5%
ACET ADICET BIO INC 0.0%
Value $163K Shares 22,779 Share Price $7.14 Est. Cost/Share $11.05 Unrealized @ Report Date -35.4%
LAB STANDARD BIOTOOLS INC 0.0%
Value $231K Shares 311,967 Share Price $0.74 Est. Cost/Share $2.41 Unrealized @ Report Date -69.3%